Diseases, Conditions, Syndromes

FDA issues warning on controversial MS treatment

(HealthDay) -- Doctors and patients need to be aware of the potential risk of injuries and death associated with an experimental treatment for multiple sclerosis called liberation therapy, the U.S. Food and Drug Administration ...

Cardiology

Platelet inhibitor reduces size of large heart attacks

The anti-platelet drug abciximab, delivered directly to lesions caused by a heart attack, significantly decreased damage to the heart muscle in high-risk patients while clot aspiration showed no impact, according to research ...

page 9 from 18